Massachusetts Financial Services’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-193,762
| Closed | -$168K | – | 921 |
|
|
2024
Q3 | $168K | Sell |
193,762
-4,692
| -2% | -$4.06K | ﹤0.01% | 839 |
|
|
2024
Q2 | $71.1K | Buy |
198,454
+6,662
| +3% | +$2.39K | ﹤0.01% | 858 |
|
|
2024
Q1 | $129K | Sell |
191,792
-424
| -0.2% | -$284 | ﹤0.01% | 836 |
|
|
2023
Q4 | $104K | Sell |
192,216
-6,072
| -3% | -$3.3K | ﹤0.01% | 830 |
|
|
2023
Q3 | $119K | Sell |
198,288
-7,597
| -4% | -$4.56K | ﹤0.01% | 833 |
|
|
2023
Q2 | $268K | Sell |
205,885
-4,850
| -2% | -$6.31K | ﹤0.01% | 800 |
|
|
2023
Q1 | $371K | Sell |
210,735
-5,958
| -3% | -$10.5K | ﹤0.01% | 814 |
|
|
2022
Q4 | $680K | Sell |
216,693
-201,869
| -48% | -$634K | ﹤0.01% | 800 |
|
|
2022
Q3 | $2.05M | Buy |
+418,562
| New | +$2.05M | ﹤0.01% | 719 |
|
|
2022
Q2 | – | Sell |
-122,387
| Closed | -$711K | – | 881 |
|
|
2022
Q1 | $711K | Buy |
122,387
+1,254
| +1% | +$7.29K | ﹤0.01% | 810 |
|
|
2021
Q4 | $908K | Buy |
121,133
+65,998
| +120% | +$495K | ﹤0.01% | 821 |
|
|
2021
Q3 | $497K | Buy |
+55,135
| New | +$497K | ﹤0.01% | 875 |
|